Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. Revisions
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
Delayed Nyse  -  04:03:15 2023-01-30 pm EST
145.65 USD   -0.43%
01/25Allergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023
PR
01/23Abbvie : St. Jude Children's Research Hospital unveils 45,000-square-foot Family Commons
PU
01/20Netflix changes management, T-Mobile US hacked again: MarketScreener's World Press Review, January 20
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
Analysis
Abbvie raises sales outlook of two new drugs to more than $17.5 billion in 2025
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions